Medical News Summary: COX-2 inhibitors need further analysis to determine the range of side effects

About: COX-2 inhibitors need further analysis to determine the range of side effects
Date: 8 December 2004
Source: Medical News Today
Medical News Summary (summary of medical news story as reported by Medical News Today): Researchers have found that patients who use rofecoxib faced three times the risk of a myocardial infarction compared to those on celecoxib. Nonselective nonaspirin NSAIDs did not seem to increase the risk of a myocardial infarction. Researchers want more studies down on the effects of the whole range of COX-2 inhibitors and believe that COX-2 inhibitors shouldn’t be used in patients at risk of cardiovascular disease or gastrointestinal toxicity unless absolutely necessary. These researcher claim that nonselective nonaspirin NSAIDs are a safer option.
URL: http://www.medicalnewstoday.com/medicalnews.php?newsid=17480
Related Disease Topics: Cardiovascular disease, Gastrointestinal toxicity, Heart disease, Myocardial infarction

---

Related Medical News Channels: This medical news summary article refers to the following medical channel categories:

• Research
• research and cardiovascular disease
• Research and gastrointestinal toxicity
• research and heart disease
• research and myocardial infarction
• cause of cardiovascular disease
• Cause of gastrointestinal toxicity
• cause of heart disease
• risk and cardiovascular disease
• Risk and gastrointestinal toxicity
• risk and heart disease
• Medication
• medication and cardiovascular disease
• Medication and gastrointestinal toxicity
• medication and heart disease
• medication and myocardial infarction

Medical Tools & Articles:

Next articles:

• Risk Factor Center
• Medical Statistics Center
• Medical Treatment Center
• Prevention Center
• Medical Tests Center

Medical Articles:

• Disease & Treatments Search
• Online Diagnosis
• Misdiagnosis Center
• Full list of interesting articles